We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App





Rapid Antigen Testing for SARS-CoV-2 Could Effectively Control COVID-19 Outbreak, Finds Study

By LabMedica International staff writers
Posted on 30 Aug 2021
Print article
Illustration
Illustration
Rapid COVID-19 antigen tests that permit new cases to isolate immediately can be important surveillance tools and effectively control COVID-19 outbreaks, according to a longitudinal comparison between antigen tests performed at home and quantitative real-time polymerase chain reaction (qRT-PCR).

Researchers at E25Bio, Inc. (Boston, MA, USA), LabCentral, Inc. (Boston, MA, USA), Harvard T. H. Chan School of Public Health (Boston, MA, USA), Mount Sinai School of Medicine (New York, NY, USA), and BioInnovation Labs, LLC (Cambridge, MA, USA) sought to validate the effectiveness of direct antigen rapid tests (DARTs) and to test whether at-home testing with DART could prevent the spread of SARS-CoV-2 in a co-working environment. The team conducted a study of high-frequency testing using inexpensive, at-home, semi-quantitative, DARTs and compared their performance with that of qRT-PCR on self-collected nasal specimens.

For the study, a total of 257 participants were enrolled who self-collected nasal swab specimens twice weekly at home during a six-month period. DART was performed at home, and the findings were compared with laboratory qRT-PCR tests. A total of 2,951 pairs of nasal swabs were self-collected by participants and tested by qRT-PCR and DART. The researchers found that that twice-weekly surveillance with DART detected infections in 15 individuals, with 96.3% sensitivity on days 0 through 3 of symptoms. Detection on day 3 is almost as effective as detection on day 1 for reducing the incidence of COVID-19, if 75% of a population is surveilled. The prevalence of disease dictates the frequency of testing and its effectiveness for controlling potential outbreaks.

COVID-19 outbreak management has been hindered by high transmission rates and limitations in testing capacity. Effective public health tools are needed for rapid and early detection. The current diagnostic standard is qRT-PCR, although its cost and long turnaround times limit its utility for widespread surveillance. However, frequent at-home testing with DART allows infected individuals to be identified and quarantined immediately. Such surveillance can prevent viral transmission in in-person work environments or other social settings, effectively controlling COVID-19 outbreaks, according to the researchers.

Related Links:
E25Bio, Inc.
LabCentral, Inc.
Harvard T. H. Chan School of Public Health
Mount Sinai School of Medicine
BioInnovation Labs, LLC


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
HLX
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
SARS-CoV-2 Test
One Step SARS-CoV-2 Nucleic Acid Detection Kit (P761H)

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: MOF materials efficiently enrich cfDNA and cfRNA in blood through simple operational process (Photo courtesy of Science China Press)

Blood Circulating Nucleic Acid Enrichment Technique Enables Non-Invasive Liver Cancer Diagnosis

The ability to diagnose diseases early can significantly enhance the effectiveness of clinical treatments and improve survival rates. One promising approach for non-invasive early diagnosis is the use... Read more

Hematology

view channel
Image: The low-cost portable device rapidly identifies chemotherapy patients at risk of sepsis (Photo courtesy of 52North Health)

POC Finger-Prick Blood Test Determines Risk of Neutropenic Sepsis in Patients Undergoing Chemotherapy

Neutropenia, a decrease in neutrophils (a type of white blood cell crucial for fighting infections), is a frequent side effect of certain cancer treatments. This condition elevates the risk of infections,... Read more

Pathology

view channel
Image: The OvaCis Rapid Test discriminates benign from malignant epithelial ovarian cysts (Photo courtesy of INEX)

Intra-Operative POC Device Distinguishes Between Benign and Malignant Ovarian Cysts within 15 Minutes

Ovarian cysts represent a significant health issue for women globally, with up to 10% experiencing this condition at some point in their lives. These cysts form when fluid collects within a thin membrane... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.